Your privacy choices

Optional analytics are off unless you choose to allow them. They help us understand public page and button usage. Essential inquiry, order and security functions remain available.

Chat messages and form contents are not marketing analytics. Read our privacy notice.

Affiliate referrals

Referral attribution is a separate choice. Allow it to recognize the affiliate who introduced you, or turn it off to stop using referral cookies.

Skip to content
Raphael Pharmaceutical
About⌄
Company overviewLeadershipMedia & PublicationsNews & Press
Science⌄
Science & PipelineResearch AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations
RaphaWell⌄
Product overviewHow to useProduct FAQAvailability
Investors⌄
Company at a GlanceStock informationSEC filingsPresentationsGovernanceInvestor Relations contact
Partner With Us⌄
Strategic partnershipsAffiliate program
ContactSign In
Explore Raphael
About⌄
Company overviewLeadershipMedia & PublicationsNews & Press
Science⌄
Science & PipelineResearch AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations
RaphaWell⌄
Product overviewHow to useProduct FAQAvailability
Investors⌄
Company at a GlanceStock informationSEC filingsPresentationsGovernanceInvestor Relations contact
Partner With Us⌄
Strategic partnershipsAffiliate program
ContactSign In
Discover RaphaWell
Representative corporate boardroom and science visual.

Company

Built around science. Focused on progress.

Raphael Pharmaceutical Inc. is a pharmaceutical research and development company focused on purified cannabinoid science, inflammatory disease and the translation of research into clinical and commercial opportunities.

Explore Science & PipelineContact Raphael
MissionStrategyLeadershipGovernance

Mission & vision

A durable scientific and operating purpose.

Company strategy and forward-looking plans remain subject to change.

Mission

Advance rigorous cannabinoid science and translate meaningful research into responsible pathways that can improve how inflammatory disease and wellness opportunities are understood and addressed.

Vision

Build a science-led pharmaceutical company where research, evidence, commercialization and collaboration work together to create durable value for patients, partners and shareholders.

What Raphael is building

A connected corporate ecosystem with distinct paths.

The design keeps scientific development, commercial wellness, collaboration and public-company transparency visibly related while preserving their appropriate boundaries.

Science

Evidence-led research

A primary scientific platform and rheumatoid arthritis lead focus.

RaphaWell

Commercial wellness initiative

A distinct commercial path separate from investigational development.

Partners

RA Network

A connected ecosystem for qualified organizations and communities.

Investors

Public transparency

A source-led center for filings, governance and company updates.

Leadership & scientific advisors

Meet the people behind Raphael.

Explore the working leadership and scientific advisory roster. Explore Raphael’s executive and scientific leadership.

Portrait of Shlomi Pilo.

Shlomi Pilo

Chief Executive Officer & Chairman

Read biography →
Portrait of Uri Tadelis.

Uri Tadelis

Chief Financial Officer

Read biography →
Portrait of Dr. Igal Louria-Hayon.

Dr. Igal Louria-Hayon

Chief Technology Officer / Chief Scientist — current role subject to confirmation

Read biography →

View all leadership & advisors

Governance

Accountability has its own public gateway.

Current governance documents, director appointments and committee records are awaiting company and legal confirmation.

Document library

Code of Ethics

The current approved Code of Ethics is awaiting publication. Contact Raphael for governance information.

Review document status →
Public company

Investor governance

Public governance information is organized separately from board-only materials.

Investor governance →
RAPHAELPHARMACEUTICAL

Science intelligence.
Greater possibilities.

Contact Raphael

About

LeadershipMedia & PublicationsNews & Press

Science

Research AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations

RaphaWell

How to useProduct FAQAvailability

Investors

Stock informationSEC filingsPresentationsGovernanceInvestor Relations contact

Partner With Us

Affiliate program

Policies

PrivacyTerms of useAffiliate termsAccessibility

© Raphael Pharmaceutical Inc.